Back

Genetic, sociodemographic, lifestyle, and clinical risk factors of heart failure aggravation events: data from the UK Biobank

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: eCardiology 3 Big Data EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Taehyun Hwang

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Spatiotemporal stability of digital twin-guided atrial fibrillation dominant frequency sites and the clinical outcome of catheter ablation
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Initial experience with a virtual atrial fibrillation clinic after pulmonary vein isolation
Doctor J. Balt (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Artificial Intelligence-based Electrocardiogram prediction for duration of Atrial Fibrillation
Doctor Y. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Predicting left atrial appendage thrombus in patients with persistent atrial fibrillation or flutter and no oral anticoagulation using machine-learning models.
Doctor B. Musielak (Nowa Sol, PL)
Abstract Slides Video
Presentation thumbnail
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram
Mr D. Mannhart (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
eCardiology 3

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Predicting progression from coronary artery disease to heart failure in community cohorts
thumbnail
Congress Presentation
Associations of infectious disease and polygenic risk score with heart failure and cardiac remodeling: findings from UK Biobank and ARIC study
thumbnail
Congress Presentation
Genome-wide association study of clinical outcomes in heart failure and Mendelian randomisation analysis of the impact of elevated body mass index on disease progression

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources